ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis

Anticoagulant treatment in patients with primary and metastatic brain cancer is a concern due to risk of intracranial hemorrhage (ICH). We performed a systematic review and meta-analysis to evaluate the risk of ICH in patients with primary or metastatic brain cancer treated with or without anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Giustozzi, Michela, Proietti, Giulia, Becattini, Cecilia, Roila, Fausto, Agnelli, Giancarlo, Mandalà, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631668/
https://www.ncbi.nlm.nih.gov/pubmed/35772127
http://dx.doi.org/10.1182/bloodadvances.2022008086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631668/
https://www.ncbi.nlm.nih.gov/pubmed/35772127
http://dx.doi.org/10.1182/bloodadvances.2022008086

Ejemplares similares